Edwards Lifesciences Corp. said Wednesday that it plans to build a heart valve plant in Changi North, Singapore.
The Irvine-based device maker said that the 98,000-square-foot plant will be the company’s third facility that makes its Carpentier-Edwards Perimount replacement tissue heart valves.
Edwards also makes valves at its headquarters, which is located off Red Hill Avenue, and in Horw, Switzerland.
The plant is set to be completed by fall 2007.
Edwards said the plant will have up to 500 workers. In the interim, the device maker plans to continue making heart valves at a facility in Kaki Bukit, Singapore.
The new Singapore plant will produce heart valves mainly for patients in the Asia Pacific region, said Randy Woodgrift, Edwards’ corporate vice president of manufacturing operations.
